Publication | Open Access
Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients
530
Citations
10
References
2022
Year
This study suggests that in the era of Omicron and in real-life settings, Paxlovid is highly effective in reducing the risk of severe COVID-19 or mortality.
| Year | Citations | |
|---|---|---|
Page 1
Page 1